In Phase A, individuals will get different doses and schedules of oral ABBV-744 tablet to establish Secure dosing routine. More participants will be enrolled with the discovered monotherapy dosign program. In Phase B, participants will receive oral ruxolitinib and ABBV-744 is going to be given as "include-on" therapy. In Section https://abbv-744brd4inhibitormech91345.iyublog.com/31400200/5-essential-elements-for-abbv-744-in-clinical-trials-for-non-small-cell-lung-cancer-nsclc